Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

JMACW

Maxpro Capital Acquisition (JMACW)

Maxpro Capital Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:JMACW

1

Data	Hora	Fonte	Título	Código	Companhia
13/01/2023	18:13	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
10/01/2023	18:05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
15/11/2022	10:00	GlobeNewswire Inc.	Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
14/09/2022	09:30	GlobeNewswire Inc.	Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
26/11/2021	11:00	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
13/10/2021	19:03	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation
07/10/2021	19:41	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering	NASDAQ:JMACW	Maxpro Capital Acquisition Corporation